Morgan Stanley Biolase, Inc Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.07 - $0.34 $17 - $85
-250 Reduced 19.39%
1,039 $0
Q1 2023

May 15, 2023
SELL
$0.28 - $0.75 $570 - $1,529
-2,039 Reduced 61.27%
1,289 $0
Q4 2022

Feb 14, 2023
SELL
$0.59 - $2.5 $3,014 - $12,775
-5,110 Reduced 60.56%
3,328 $2,000
Q3 2022

Nov 14, 2022
SELL
$2.43 - $5.53 $37,934 - $86,328
-15,611 Reduced 64.91%
8,438 $21,000
Q2 2022

Aug 15, 2022
BUY
$3.42 - $8.75 $82,247 - $210,428
24,049 New
24,049 $111,000

Others Institutions Holding BIOL

# of Institutions
2
Shares Held
56
Call Options Held
0
Put Options Held
0
View Full List

About BIOLASE, INC

BIOL Quotes by TradingView
  • Ticker BIOL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,260,180
  • Market Cap $82.6K
  • Description
  • BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive de...
More about BIOL
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email